Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway. NJPS [Интернет]. 11 апрель 2026 г. [цитируется по 12 апрель 2026 г.];40(2). доступно на: https://ojshostng.com/index.php/njphysiologicalsciences/article/view/4001